Blue Bell, PA · Founded 2018 · Privately Held (backing)
Developer of cell-based therapies designed to offer therapeutics and vaccines for solid cancer. Seneca Therapeutics is based in Blue Bell, PA and was founded in 2018. It was valued at $51 million at its later-stage round in Jul 2025, the last priced event on record. It has raised $25.2 million across 5 recorded rounds; the latest was a $1.6 million seed round in Dec 2024.
PMV mark · valuation
$51.0M
Oct 2026
Priced at
its later-stage round
Jul 2025
Total raised
$25.2M
Last round
Seed Round
Dec 2024
Cap table — not yet on record
Seneca Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Seneca Therapeutics with a free account
·The complete investor list: 14 names
·Watch Seneca Therapeutics: the Monday email on marks, rounds and moves
Where does Seneca Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Seneca Therapeutics's 5 recorded funding rounds.
